In a clinical trial called SURMOUNT-5, people who used Zepbound over 72 weeks lost 20.2% of their body weight, compared to 13.7% in people who used Wegovy
Bottom Line: Peptides like BPC-157 and TB-500 are reshaping recovery and performance strategies for athletes
DPP-4 inhibition with alogliptin on top of angiotensin II type 1 receptor blockade ameliorates albuminuria via up-regulation of SDF-1a in type 2 diabetic patients with incipient nephropathy
With tirzepatide, non-oral contraceptive methods should be considered for 4 weeks after initiation and dose increases due to reduced oral contraceptive efficacy
Zepbound comes in 6 strengths 2.5, 5, 7.5, 10, 12.5, and 15 mg
Long-Term Effects of GLP-1 The question that many people would pose is: What are the negative side effects of GLP-1 in the long-term